Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The Cohort C2 of this Platfom study (NCT05750628) is the open‐label, randomized, two‐armcombination therapy evaluating a single oral dose of up to three anti‐malarial agents asa loose combination vs. standard of care (SoC), Coartem in children aged 2 to <12 years.
Epistemonikos ID: 4db762c5adf72ff354cbbe22a9a9ce7d769cfa3b
First added on: Sep 11, 2026